A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Investigators assessed whether intravesical BCG is necessary for patients with high-grade T1 nonmuscle-invasive bladder cancer who have unremarkable histology on the second transurethral resection.

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, ...

There are about 80,000 new cases of bladder cancer every year in the US alone ... This research has determined that ...

Rana R. McKay, MD, discusses the significance of clinical trial data for immunotherapy in muscle-invasive bladder cancer (MIBC) treatment she presented at a Case-Based Roundtable event.

I DIDN’T KNOW IT WAS VERY UNPREDICTABLE. A CANCER DIAGNOSIS IS NOT A DEATH SENTENCE. AFTER SIX MONTHS OF CHEMO, SURGERY AND PHYSICAL THERAPY, TIFFANY IS NOW CANCER FREE. SHE ALSO DECIDED TO ...

with Keytruda or Keytruda plus a placebo in the adjuvant setting. To be eligible for the trial, patients must have stage II, IIIA, or IIIB NSCLC and have not achieved pathological complete response ...

Women who participated in aerobics while on chemo reported feeling sharper, with a better quality of life However, they did not score better on objective brain function tests WEDNESDAY, Oct. 23, 2024 ...

Using a gene signature technique to tailor chemotherapy for ... to tailor individualized adjuvant therapy for patients with operable triple negative breast cancer." "In addition, this study ...

Pertuzumab (Perjeta) treats HER2-positive early breast cancer, usually in combination with trastuzumab and chemotherapy. It’s FDA-approved for neoadjuvant and adjuvant treatment. Neoadjuvant use ...

Two main methods have been proposed in relation to bladder ART ... 48% of patients received neoadjuvant or adjuvant radiotherapy and/or chemotherapy. § 24% of patients received postoperative ...

1Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania. 2Division of Hematology-Oncology, Edmond and Lily Safra Children’s ...